New data on Orqis Medical's Cancion® CRS™ to be reported at ACC
Orqis Medical's Cancion CRS therapy has shown promising results in improving cardiac index and pulmonary capillary wedge pressure in patients with severe heart failure. The therapy provides continuous aortic flow augmentation, enabling progressive hemodynamic improvement without taking over the heart's function.